SOZIO, Piera
 Distribuzione geografica
Continente #
NA - Nord America 3.294
EU - Europa 2.478
AS - Asia 2.225
SA - Sud America 196
AF - Africa 38
Continente sconosciuto - Info sul continente non disponibili 4
Totale 8.235
Nazione #
US - Stati Uniti d'America 3.235
SG - Singapore 833
CN - Cina 681
UA - Ucraina 385
IT - Italia 345
GB - Regno Unito 335
IE - Irlanda 316
FR - Francia 255
SE - Svezia 243
TR - Turchia 229
RU - Federazione Russa 216
VN - Vietnam 200
DE - Germania 172
BR - Brasile 168
IN - India 162
FI - Finlandia 89
CA - Canada 37
PL - Polonia 25
BE - Belgio 23
HK - Hong Kong 23
ES - Italia 22
BD - Bangladesh 19
CZ - Repubblica Ceca 18
AR - Argentina 14
IQ - Iraq 14
MX - Messico 14
ZA - Sudafrica 13
LT - Lituania 12
IR - Iran 11
KE - Kenya 9
KR - Corea 9
JP - Giappone 8
PK - Pakistan 7
ID - Indonesia 6
UZ - Uzbekistan 5
EU - Europa 4
IL - Israele 4
SA - Arabia Saudita 4
TN - Tunisia 4
AL - Albania 3
CO - Colombia 3
EG - Egitto 3
GR - Grecia 3
PE - Perù 3
PY - Paraguay 3
CG - Congo 2
CH - Svizzera 2
CL - Cile 2
CR - Costa Rica 2
DZ - Algeria 2
EE - Estonia 2
ET - Etiopia 2
HU - Ungheria 2
JO - Giordania 2
MA - Marocco 2
NL - Olanda 2
PH - Filippine 2
RO - Romania 2
AM - Armenia 1
AT - Austria 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
JM - Giamaica 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 8.235
Città #
Singapore 654
Chandler 415
Jacksonville 413
San Jose 366
Dublin 312
Southend 244
Ashburn 234
Beijing 150
Princeton 138
Dallas 134
Nanjing 124
Izmir 116
Chieti 99
Dearborn 94
Santa Clara 74
Los Angeles 71
Ho Chi Minh City 70
Cambridge 69
Wilmington 66
Ann Arbor 59
The Dalles 56
Altamura 55
Tongling 54
New York 52
Munich 48
Hanoi 47
Nanchang 44
Boardman 35
Shenyang 31
Buffalo 29
Washington 25
Tianjin 24
Brussels 23
Moscow 23
Kunming 22
Kocaeli 20
Hong Kong 19
Brno 18
São Paulo 18
Woodbridge 18
Montreal 17
Jiaxing 16
Frankfurt am Main 15
Grevenbroich 15
Hebei 15
Orem 15
Warsaw 15
Chennai 14
Ningbo 14
Zhengzhou 14
Jinan 13
Leawood 13
Pescara 13
Augusta 12
Brooklyn 12
Haiphong 12
Hefei 12
Helsinki 12
Redondo Beach 12
Houston 11
Johannesburg 11
Boston 10
London 10
Toronto 10
Ardabil 9
Nairobi 9
Turku 9
Atlanta 8
Bexley 8
Denver 8
Guangzhou 8
Poplar 8
Seoul 8
Teramo 8
Auburn Hills 7
Biên Hòa 7
Mumbai 7
Seattle 7
Tokyo 7
Da Nang 6
Dhaka 6
Hangzhou 6
Kraków 6
Mexico City 6
Milan 6
Naples 6
Phoenix 6
San Mateo 6
Simi Valley 6
West Jordan 6
Chicago 5
Falls Church 5
Guarulhos 5
Lanzhou 5
Norwalk 5
Ottawa 5
Porto Alegre 5
Stockholm 5
Baghdad 4
Bari 4
Totale 5.108
Nome #
Viscoelastic properties of Staphylococcus aureus and Staphylococcus epidermidis mono-microbial biofilms 237
(R)-α-Lipoyl-glycyl-L-prolyl-L-glutamyl dimethyl ester codrug as a multifunctional agent with potential neuroprotective activities 194
A glutathione derivative with chelating and in vitro neuroprotective activities: synthesis, physicochemical properties, and biological evaluation. 171
Synthesis of a novel cyclic prodrug of S -allyl-glutathione able to attenuate LPS-induced ROS production through the inhibition of MAPK pathways in U937 cells 167
Solid lipid nanoparticles loaded with lipoyl-memantine codrug: preparation and characterization 161
Ibuprofen and glutathione conjugate as a potential therapeutic agent for treating Alzheimer's disease 156
CNS delivery of L-Dopa by a new Hybrid Glutathione-Methionine peptidomimetic prodrug 154
Potential Antibacterial Activity of Carvacrol-Loaded PLGA Nanoparticles against Microbial Biofilm 153
Characterization of alkanoyl-10-O-minocyclines in micellar dispersions as potential agents for treatment of human neurodegenerative disorders 152
Detection of levodopa, dopamine and its metabolites in rat striatum dialysates following peripheral administration of L-DOPA prodrugs by mean of HPLC-EC 147
Synthesis and preliminary pharmacological evaluation of 2,3,4,8,13a-hexahydro-1H-benzo(5,6)cyclohepta(1,2,3-ef)(3)benzazepine-6,7-diol derivatives as dopamine receptor ligands 146
Antiparkinson Prodrugs 145
Synthesis and evaluation of trans-2-amino-5(or 6)-chloro-6(or 5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as dopamine receptor ligands 143
Synthesis and preliminary evaluation of L-dopa/benserazide conjugates as dual acting codrugs 141
A new lipophilic molecular combination codrug-1 exerts neuroprotective activity in beta amyloid (1-40) infused Alzheimer’s disease rat model 140
Evaluation of 2,3,4,8,13a hexahydro-1H-Benzo[5,6]cyclohepta-6,7-dihydroxy[1,2,3-ef][3]benzazepine derivatives as dopamine receptor ligands 139
Gold nanoparticles as scaffolds for new antiparkinson prodrugs 139
Sintesi di trans-2-ammino-1-fenil-5-fluoro-6-idrossi (e 6-fluoro-5-idrossi)-2,3-diidro-1H-indeni quali potenziali ligandi per i recettori dopaminergici 136
Design, synthesis and preliminary pharmacological evaluation of new imidazolinones as L-DOPA prodrugs. 136
L-Dopa Prodrugs: An Overview of Trends for Improving Parkinson's Disease Treatment 136
Codrugs Linking l-Dopa and Sulfur-Containing Antioxidants: New Pharmacological Tools against Parkinson’s Disease 135
Design and synthesis of multifunctional drugs: a strategy to improve the treatment of Parkinson’s disease 132
Synthesis and Study of L-Dopa-Glutathione Codrugs as New Anti-Parkinson Agents with Free Radical Scavenging Properties. 131
New drug delivery strategies for improved Parkinson’s disease therapy 131
Evaluation of rat striatal L-Dopa and DA concentration after intraperitoneal administration of L- Dopa prodrugs in liposomal formulations 130
Biodegradable microspheres loaded with an antiparkinson prodrug: an in vivo pharmacokinetic study 130
synthesis and Activity of L-Dopa-Thiol antioxidant Co-drugs and New anti-PArkinson Agents with free Radical Scavenging Properties 129
Designing Prodrugs for the Treatment of Parkinson's Disease 127
Memantine-sulphur containing antioxidant conjugates as potential prodrugs to improve the treatment of Alzheimer’s disease 125
Ibuprofen and lipoic acid diamide as co-drugs with neuroprotective activity: pharmacological properties and effects in β-amyloid (1-40) infused Alzheimer’s disease rat model. 124
Synthesis and preliminary pharmacological evaluation of trans-2-amino-5(6)-chloro-6(5)-hydroxy-1- phenyl-2,3-dihydro-1H-indenes as dopamine receptor ligands 123
L-Dopa- and dopamine- (R)-α-lipoic acid conjugates as multifunctional codrugs with antioxidant properties 121
synthesis and biological evaluation as anti-Parkinson agent of an analogue of Glutathione-L-Dopa containing methionine in place of the cysteinil residue 121
Preparation and pharmacological characterization of trans-2-amino-5(6)-fluoro-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as D2-like dopamine receptor agonists 121
Ibuprofen and lipoic acid diamides as potential codrugs with neuroprotective activity 120
Drug Delivery Strategies for Alzheimer's Disease Treatment 120
Synthesis and biological evaluation of a novel pyroglutamil-modified TRH analogue 119
Nuovi S-coniugati del glutatione ad attività inibitoria nei confronti delle GST umane 119
Maleic- and Fumaric-diamides of (O,O-diacetyl)-L-Dopa-methylester as anti-Parkinson prodrugs in liposomal formulation 117
Transdermal donepezil on the treatment of Alzheimer’s disease 117
NOS-mediated morphological and molecular modifications in rats infused with Aβ (1-40), as a model of Alzheimer’s Disease, in response to a new lipophilic molecular combination codrug-1 116
Dimeric L-dopa derivatives as potential prodrugs. 115
Potent isozyme-selective inhibition of human glutathione S-transferase A1-1 by a novel glutathione S-conjugate 115
Glycosyl and polyalcoholic prodrugs of lonidamine 114
Ibuprofen and lipoic Acid conjugate neuroprotective activity is mediated by ngb/akt intracellular signaling pathway in Alzheimer's disease rat model 113
Transition state isosteres of the gamma-glutamyl peptide bond hydrolysis: synthesis and characterization of the psi (CH2NH) pseudopeptide analogue of glutathione 112
Dopaminergic system modulation, behavioral changes, and oxidative stress after neonatal administration of pyrethroids 108
Evaluation of cytotoxic, oxidative stress and genotoxic responses of hydroxyapatite nanoparticles on human blood cells 107
New Flurbiprofen Derivatives: Synthesis, Membrane Affinity and Evaluation of in Vitro Effect on β-Amyloid Levels 106
Preparation and characterization of poly(lactic-co-glycolic acid) microspheres loaded with a labile antiparkinson prodrug 105
Synthesis and activity of novel glutathione analogues containing an urethane backbone linkage 104
New L-Dopa codrugs as potential antiparkinson agents 104
Multifuctional L-Dopa Codrugs Containing Antioxidant Molecules 103
The Investigation of Cytogenetic and Oxidative Effects of Diffractaic Acid on Human Lymphocyte Cultures 102
Protective effects of cyclosativene on H2O 2-induced injury in cultured rat primary cerebral cortex cells 102
Effect of treatment with choline-contining Phospholipids on brain neurontransmitter transporters 101
Ibuprofen-Glutathione Conjugate as Anti-inflammatory and Anti-apoptotic Agent in Rat Brain Infused with β Amyloid (1-40) 101
Effect of choline-containing phospholipids on brain cholinergic transporters in the rat. 98
Modulation of monoaminergic transporters by choline-containing phospholipids in rat brain 94
Haloperidol metabolite II prodrug: Asymmetric synthesis and biological evaluation on rat C6 glioma cells 92
Synthesis and biological evaluation of oligopeptides with antioxidant activity useful for treatment of neurodegenerative diseases 89
Novel O-palmitoylscleroglucan-coated liposomes as drug carriers: Development, characterization and interation with leuprolide 87
pPKC alpha.mediated effect on in vitro AB production in response to gamma secretase inhibitor LY411575in rat CTXTNA2 astrocytes. 85
Ibuprofen and lipoic acid codrug 1 control Alzheimer's disease progression by down - regulating Protein Kinase C ε – mediated Metalloproteinase 2 and 9 levels in β-amyloid infused Alzheimer's disease rat model 79
Lipid nanocarriers containing a levodopa prodrug with potential antiparkinsonian activity 70
In vivo anti-apoptotic effect of compound 4 in rats infused with Abeta (1-40), as a model of Alzheimer's disease 68
In vivo anti-apoptotic effect of compound 4 in rats infused with Aβ (1-40), as a model of Alzheimer’s disease 67
Novel imidazoline compounds as partial or full agonists of D2-likedopamine receptors inspired by I2-imidazoline binding sites ligand 2-BFI 63
Neuroprotective effects of farnesene against hydrogen peroxide-induced neurotoxicity in vitro 59
Totale 8.364
Categoria #
all - tutte 33.568
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.568


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202184 0 0 0 0 0 0 0 0 0 0 67 17
2021/2022306 5 7 6 44 29 7 7 25 45 17 32 82
2022/20231.096 79 171 62 129 94 229 54 91 122 17 24 24
2023/2024493 35 23 43 12 37 152 125 4 5 5 1 51
2024/20251.202 65 223 183 12 9 115 31 29 73 41 166 255
2025/20262.336 233 99 230 265 229 178 481 144 233 192 52 0
Totale 8.364